Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Use of DNAse in Neutrophilic Asthma
NCT03994380Phase 2Completed
- Sponsor
- National Jewish Health
- Start
- Feb 2020
- Primary completion
- May 2022
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of dornase alfa in neutrophilic asthma, sponsored by National Jewish Health. Started Feb 2020; status: completed.
02
Drugs
dornase alfa
03
Conditions
neutrophilic asthma
Beyond the preview
Go deeper on NCT03994380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03994380.